AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS

URLhttps://www.amgen.com/newsroom/press-releases/2025
SourceAmgen
Date Published09/02/2025

Additional Reshoring Information:

Company/Division name Amgen
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2025
Domestically, the work will be done:In-house
Capital investment ($):600
City reshored to:Thousand Oaks
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharma, theraputics
Find Reshoring Articles